Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
disease
|
| gptkbp:associated_with |
diabetes
alcohol consumption obesity non-alcoholic fatty liver disease aflatoxin exposure |
| gptkbp:can_be |
ascites
jaundice portal hypertension |
| gptkbp:causedBy |
genetic factors
toxic substances viral infections |
| gptkbp:controls |
maintaining a healthy weight
avoiding alcohol vaccination against hepatitis B |
| gptkbp:demographics |
increasing
|
| gptkbp:designatedAs |
hepatocellular carcinoma
primary liver cancer |
| gptkbp:diseaseResistance |
biopsy
poor imaging tests elevated liver enzymes alpha-fetoprotein test |
| gptkbp:has_a_focus_on |
research funding
|
| https://www.w3.org/2000/01/rdf-schema#label |
Leber-Krebs
|
| gptkbp:impact |
liver
surgery radiation therapy chemotherapy |
| gptkbp:is_monitored_by |
healthcare_professionals
|
| gptkbp:is_recognized_for |
gptkb:World_Health_Organization
|
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:is_used_in |
men
older adults specialized cancer centers |
| gptkbp:issues |
public health
|
| gptkbp:leads |
liver failure
metastasis |
| gptkbp:number_of_stages |
stage I
stage IV stage II stage III |
| gptkbp:reportsTo |
medical literature
|
| gptkbp:riskManagement |
cirrhosis
chronic hepatitis B chronic hepatitis C |
| gptkbp:symptoms |
nausea
weight loss abdominal pain |
| gptkbp:worksWith |
immunotherapy
targeted therapy |